ArticleCureus2025
Colorectal Cancer in Young Patients: Experience From Avicenne Military Hospital, Marrakech.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColorectal cancer (CRC) in young adults is an increasingly significant global health concern. Several studies have documented a rise in its incidence and tumor aggressiveness, yet no specific management recommendations exist for this age group. This study aims to describe the clinical, therapeutic, and prognostic characteristics of young patients treated for CRC at our center.
methodsThis retrospective study was conducted at the Medical Oncology Department of Avicenne Military Hospital in Marrakech, covering the period from January 2019 to December 2023. Twenty-eight patients under 50 years of age diagnosed with CRC were included and analyzed.
resultsAmong the 28 patients, the mean age at diagnosis was 31.9 years, with a slight male predominance (n = 15; sex ratio 1.15). Four patients were active smokers (14%), one was a chronic alcohol user, and two had a family history of CRC (7%). The most frequent presenting symptoms were abdominal pain (11 cases, 39%), constipation (8 cases, 28%), bowel obstruction (6 cases, 21%), and gastrointestinal bleeding (3 cases, 10%). Tumor location was predominantly in the right colon (n = 15, 53.5%), followed by the left colon (n = 11, 39.2%) and the rectum (n = 2, 7.1%). The most common histological type was Lieberkühnian adenocarcinoma, found in 71.5% of cases (n = 20). Among metastatic patients, the median progression-free survival was 25 months.
conclusionCRC in young adults presents an aggressive clinical profile. Improved outcomes require earlier diagnosis, particularly in patients with predisposing factors, and the development of specialized expert centers for optimal management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.